Skip to content
Screener

PP&E (Net) at other companies

Insulet logo
InsuletPODD
$858.6M+19.2%
Medtronic logo
MedtronicMDT
$7.42B+8.5%
Beta Bionics logo
Beta BionicsBBNX
$10.75M+66.2%
Embecta Corp. logo
Embecta Corp.EMBC
$316.8M+20.6%
AdaptHealth logo
AdaptHealthAHCO
$622.19M+29.2%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$3.22M-18.0%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.56B+128%
Enterprise value$2.23B+109%
P/S1.5×+0.8×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
AssetsJune 30, 2026 / (Unaudited)December 31, 2025 / (Note 1)
Inventories135,106128,769
Prepaid and other current assets51,47231,217
Total current assets804,639618,143
Property and equipment, net84,50183,580
Operating lease right-of-use assets100,18596,172
Equity method investment132,27160,351
Other long-term assets32,60622,866
Total assets$1,154,202$881,112

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's PP&E (net)?
Tandem Diabetes Care (TNDM) reported PP&E (net) of $84.5M in Q2 2026.
How has Tandem Diabetes Care's PP&E (net) changed year-over-year?
Tandem Diabetes Care's PP&E (net) increased by 9.0% year-over-year, from $77.51M to $84.5M.
What is the long-term trend for Tandem Diabetes Care's PP&E (net)?
Over 5 years (2020 to 2025), Tandem Diabetes Care's PP&E (net) has grown at a 10.8% compound annual growth rate (CAGR), from $50.02M to $83.58M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Tandem Diabetes Care's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude